In September we received regulatory approval to expand the list of supported smartphones for IBDoc®. Like for the previous approvals, we used our established thorough validation control to add 12 additional models. Since each smartphone model differs in camera and processor type, which relates to differences in measurement we always need to make sure that the supported […]
New Smartphone Models Supported Read More »
In December we received regulatory approval to expand the list of supported smartphones for IBDoc. To achieve this we established a thorough validation control to be able to include new smartphones. Since each smartphone model differs in camera and processor type, which relates to differences in measurement we always need to make sure that the supported
New Supported Smartphones Read More »
IBDoc® is now available in Australia. IBDoc® achieved the CE certification in April 2015 for self-testing making it available to patients throughout Europe. Now a second major milestone has been reached. The Australian Health Authorities TGA (Therapeutic Goods Administration), approved the use of IBDoc®. This means that IBDoc® can now be made available to all Australian IBD patients
IBDoc TGA approved for Australia Read More »
Basel, April 2nd, 2015 – BÜHLMANN is pleased to announce the launch of IBDoc®, the first in-vitro diagnostic test to measure the fecal inflammation marker calprotectin at home. IBDoc® just received a CE mark for patient self testing and is a revolutionary new test for gut inflammation aimed at people with Inflammatory Bowel Disease, Crohn’s and Ulcerative Colitis
BÜHLMANN launches IBDoc® – the first CE marked Calprotectin Home Test Read More »
